This is the first NAP on the Prevention and Containment of AMR in Kenya. It has been developed based on the National Policy on Prevention and Containment of AMR and the recommendations of the situation analysis on AMR conducted in 2011 and updated in 2016. This strategy provides a regulatory and imp...lementation framework to establish and strengthen systems to contain the emergence and spread of AMR. Implementation of this strategy will require substantial funding and high-level political commitment. Because AMR is a multidisciplinary and intersectoral issue, successful implementation of this strategy will require effective coordination and collaboration among different sectors.
more
Deployment of Residents in Various Facilities Designated for Screening and Management of Patients with COVID-19 and the non covid area of the hospital (in this SOP, the term “resident” includes DNB and CPS students)
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was... to facilitate the development of pharmacovigilance systems in the Region of the Americas and improve, strengthen, and promote the adoption of good practices to improve safety for patients and the general population, based on the needs of the Region.
Document also available in Spanish and Portuguese!
more
WG Implementation Guidelines Tool 4
This publication marks the 25th anniversary of the Beijing Declaration and Platform for Action. It is dedicated to the women leaders and allied community mobilizers who have devoted their lives to advancing the human rights and dignity of all people affected by the HIV epidemic, and to opposing soci...al injustice, gender inequality, stigma and discrimination, and violence. Unless otherwise indicated, the HIV-related statistics cited in this publication reflect the most recent UNAIDS data available.
more
COVID-19 is a disease caused by a new strain of coronavirus, a new coronavirus associated with the severe acute respiratory syndrome (SARS) viruses family and some coronaviruses associated with common cold.
There is still no evidence that persons living with HIV have a higher risk of contracting CO...VID-19 or if they will experience further complications of the disease, in case of contracting it. Nevertheless, it is very important that persons with HIV take all necessary precautions to prevent the spread.
more
Этот документ, содержащий ответы на часто задаваемые вопросы, дополняет временные рекомендации ВОЗ «Клиническое руководство по ведению пациентов с тяжелой остро... респираторной инфекцией при подозрении на инфицирование новым коронавирусом» и посвящен вопросам в связи с этими рекомендациями.
Во временных рекомендациях и настоящем документе отражены:
i. имеющиеся сведения в отношении риска заражения COVID19 через грудное молоко;
ii. сведения о благотворном воздействии грудного вскармливания и контакта «кожа к коже»;
iii. сведения о неблагоприятном воздействии детских молочных смесей в случае неправильного
использования.
COVID-19 and breastfeeding (frequently asked questions)
more
Advances in Infectious Diseases, 2015, 5, 57-62
Published Online March 2015 in SciRes.
Q1: In individuals with psychotic disorders (including schizophrenia), are antipsychotic drugs safe and effective?
31 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
Countries around the world are rolling ou...t COVID-19 vaccines, and a key topic of interest is their safety. Vaccine safety is one of WHO’s highest priorities, and we’re working closely with national authorities to develop and implement standards to ensure that COVID-19 vaccines are safe and effective.
more